|
| 产地 | 中国 |
| 品牌 | Chemstan |
| 货号 | CSD00687 |
| 保存条件 | store at -80癈 |
| 用途 | 仅用于科研用途 |
| 应用范围 | |
| 抗原来源 | CHO cells |
| CAS编号 | |
| 保质期 | |
| 抗体名 | Certolizumab ( 赛妥珠单抗 ) |
| 是否单克隆 | |
| 克隆性 | |
| 靶点 | TNF(DIF,TNF-alpha,TNFA,TNFSF2,cachexin,cachectin,TNFα) [Homo sapiens] |
| 适应物种 | |
| 形态 | |
| 宿主 | |
| 标记物 | |
| 包装规格 | 100μg |
| 纯度 | % |
| 亚型 | |
| 标识物 | |
| 浓度 | 95% |
| 免疫原 | |
| 是否进口 | 否 |
产品货号：CSD00153
类别：单克隆抗体药物类似物
靶点;物种(Specificity target name;species)：TNFSF2/TNF-alpha/TNFA[Homo sapiens]
种类(Species)：Humanized
受体鉴定(Receptor identification)：Fab'-G1-kappa
货号（Catalog No.）
CS00153
通用名INN
Certolizumab Pegol
纯度(Purity)
>95%
浓度( Concentration)
1mg/ml
Formulation
PBS buffer pH7.5
Source
CHO cells
内毒素(Endotoxin level)
Please contact with the lab for this information.
产品描述(Description)
Certolizumab pegol is a pegylated monoclonal antibody against the tumor necrosis factor-alpha (TNF-alpha).1 It is formed with a humanized Fab fragment of 50 kDa, from an IgG 1 isotype, fused to a 40 kDa polyethylene glycol moiety replacing the Fc antibody region. The absence of the Fc region was ideated to prevent complement fixation and antibody-mediated cytotoxicity as well as to markedly increase its half-life.
别名(Alternative names)
CDP870,PHA-738144
靶点;物种(Specificity target name;species)
TNFSF2/TNF-alpha/TNFA[Homo sapiens]
种类(Species)
Humanized
受体鉴定(Receptor identification)
Fab'-G1-kappa
